$Neumora(NMRA)$ 惨NMRA announced that the Phase 3 KOASTAL-1 study of navacaprant for major depressive disorder did not show a statistically significant improvement in the primary endpoint of change in MADRS score at Week 6 or the key secondary endpoint of SHAPS score. The

$Neumora(NMRA)$

惨

NMRA announced that the Phase 3 KOASTAL-1 study of navacaprant for major depressive disorder did not show a statistically significant improvement in the primary endpoint of change in MADRS score at Week 6 or the key secondary endpoint of SHAPS score. The KOASTAL-2, KOASTAL-3, and KOASTAL-LT studies are ongoing

cns bio一天跌八成。重度抑郁催化剂完蛋了 KOR

发布于上海